Originally published In Press as doi:10.1074/jbc.M002571200 on April 20, 2000
J. Biol. Chem., Vol. 275, Issue 26, 19808-19818, June 30, 2000
Selective Interaction of Complexin with the Neuronal SNARE
Complex
DETERMINATION OF THE BINDING REGIONS*
Stefan
Pabst
,
James W.
Hazzard§¶,
Wolfram
Antonin
,
Thomas C.
Südhof
,
Reinhard
Jahn
,
Josep
Rizo§, and
Dirk
Fasshauer
**
From the
Department of Neurobiology,
Max-Planck-Institute for Biophysical Chemistry, D-37077
Göttingen, Germany, the § Departments of Biochemistry
and Pharmacology, University of Texas Southwestern Medical Center,
Dallas, Texas 75235, and the
Departments of Molecular Genetics,
Howard Hughes Medical Institute and Center for Basic Neuroscience,
University of Texas Southwestern Medical Center, Dallas, Texas
75235
Received for publication, March 24, 2000
 |
ABSTRACT |
Complexins are evolutionarily conserved proteins
that specifically bind to soluble
N-ethylmaleimide-sensitive factor attachment protein
receptor (SNARE) complexes and thus may regulate SNARE function. Using
purified proteins, we have performed a detailed analysis of the
structure of complexin and of its interaction with SNARE proteins. NMR
spectroscopy revealed that isolated complexins have no tertiary
structure but contain an unusual
-helical middle domain of
approximately 58 amino acids that overlaps with the most highly
conserved region of the molecules. Complexins form a stable
stoichiometric complex with the central domain of the ternary SNARE
complex, whereas no binding was observed to monomeric SNAREs. Using a
combination of limited proteolysis, deletion mutagenesis, and NMR
spectroscopy, we found that the helical middle region of complexin is
responsible for binding to the SNARE complex. Binding was highly
sensitive to substitution of syntaxin 1 or synaptobrevin 2 with other
SNARE homologs but less sensitive to substitution of SNAP-25. In
addition, a stretch of 12 amino acids in the middle of the SNARE motif
of syntaxin 1A was able to confer binding activity to the non-binding
relative syntaxin 4. Furthermore, disassembly of ternary complexes is
not affected by complexins. We conclude that complexins are specific
ligands of the neuronal core complex that bind with a central
-helical domain, probably to the middle of the surface groove formed
by synaptobrevin and syntaxin. Complexins may regulate the function of
ternary complexes and control membrane fusion through this interaction.
 |
INTRODUCTION |
Intracellular membrane fusion events are mediated by conserved
sets of membrane-bound proteins referred to as
SNAREs1 (acronym for soluble
N-ethylmaleimide-sensitive factor attachment protein
receptors) (1). SNAREs comprise a family of proteins that is
distinguished by the presence of the SNARE motif, a homologous stretch
of approximately 60 amino acids that is usually localized adjacent to
the membrane anchor domains (2-4). Best characterized are SNARE
proteins functioning in neuronal exocytosis. They include the synaptic
vesicle protein synaptobrevin (also referred to as vesicle-associated
membrane protein), and the synaptic plasma membrane proteins SNAP-25
and syntaxin 1. These proteins form a stable ternary complex, the core
complex, that can be reversibly disassembled by the ATPase NSF
(N-ethylmaleimide-sensitive factor) and additional cofactors
termed SNAPs (for soluble NSF attachment proteins) (5).
Studies performed largely on recombinant proteins in solution have
revealed a detailed picture of SNARE complex assembly. Of the monomeric
SNAREs, only syntaxin 1 is partially
-helical, whereas both SNAP-25
and synaptobrevin are largely unstructured. Upon assembly, a dramatic
increase in
-helical content is observed suggesting major
conformational changes (6, 7). Interactions in the complex are largely
confined to the SNARE motifs. X-ray crystallography revealed that the
assembled core complex consists of an elongated bundle of four
intertwined
-helices, each representing a single SNARE motif. Two of
the helices are contributed by SNAP-25, and one each by syntaxin 1 and
synaptobrevin (8). The core complex is resistant to proteolysis and to
denaturation by the detergent SDS (unless heated) (9). Furthermore, it
is unusually heat-stable and only denatures above 80 °C (10). These
and other findings suggested that SNARE complex assembly is the
essential step in initiating membrane fusion. According to this
hypothesis, assembly of SNAREs localized on the two opposing membranes
form a tight connection between the membranes. In the resulting
"trans" complexes, the SNARE motifs are partially
assembled in a helical bundle, while the transmembrane domains are
anchored in the still separated membranes. The energy released during
assembly may, at least partially, overcome the barrier separating the
membranes destined to fuse. During fusion, the SNAREs relax into a
complex in which all transmembrane domains are aligned in parallel
("cis" complex) and which then is re-energized by
disassembly involving NSF and SNAPs (11).
In search for molecules regulating the function of neuronal SNAREs,
several proteins have been identified that bind specifically to
individual SNAREs or to SNARE core complexes (4). Among these are the
complexins, two related proteins of approximately 15 kDa. Complexins,
also named synaphins, were identified as polar and soluble proteins
that are associated with the neuronal SNARE complex in membrane
extracts (12-14). In vitro, complexins bind to assembled
SNAREs and compete with
-SNAP for binding (12), suggesting that they
are involved in the regulation of the SNARE assembly-disassembly cycle.
Both complexins are colocalized with neuronal SNAREs in presynaptic
nerve terminals, although cytoplasmic pools are also present,
particularly during early stages of neuronal maturation (15).
The precise function of the complexins remains to be elucidated. When
the intracellular concentration of complexin was increased by
microinjection or by overexpression, a moderate reduction of neurotransmitter release was observed. Injection of an
anti-complexin antibody increased transmitter release, suggesting that
complexins may function as negative regulators (15, 16). Disruption of the complexin II gene in mice resulted in viable mice with all parameters of synaptic transmission being normal except long term potentiation (17). However, disruption of both complexin genes causes
massive neurological
dysfunctions,2 indicating
that complexins are essential for synaptic function.
Here we have used a combination of biochemical and biophysical
approaches to learn more about complexins and their interactions with
SNAREs. First, we have characterized the structure of complexins. Second, we have investigated which domains of complexins are involved in binding to the SNARE complex, which structural elements of the
SNAREs participate in the interaction, and how complexins influence the
assembly-disassembly reactions of the SNARE proteins.
 |
EXPERIMENTAL PROCEDURES |
Materials--
NSF and
-SNAP in pQE-9 plasmids (Qiagen)
encoding for His6-tagged fusion proteins were kindly
provided by S. Whiteheart and J. E. Rothman (Memorial
Sloan-Kettering Cancer Center, New York, NY). The recombinant protein
fragments were derived from cDNAs encoding for rat synaptobrevin 2 and rat syntaxin 1A (kindly provided by R. H. Scheller, Stanford
University School of Medicine, Stanford, CA; Refs. 18 and 19).
Recombinant Proteins--
The pET-28a and pET-15b vector
(Novagen) encoding for thrombin cleavable amino-terminal
His6-tagged fusion proteins were used for the expression of
the following constructs: rat synaptobrevin 2 (residues 1-116), the
cytoplasmic region of synaptobrevin 2 (residues 1-96), the cytoplasmic
domain of rat syntaxin 1A (residues 1-262), the SNARE complex forming
part of syntaxin 1A (residues 180-262), syntaxin 1A (183-288),
full-length rat SNAP-25A, SNAP-25 (1-83), and SNAP-25 (120-206). In
full-length SNAP-25A, all cysteines were replaced with serines as
described earlier (10, 20, 21). pHO-2 vectors encoding for
COOH-terminal His6-tagged fusion proteins (7) were used for
rat syntaxin 1A (1-265), syntaxin 2 (1-265), syntaxin 3 (1-260),
syntaxin 4 (1-273), and rat SNAP-25A (1-206) (7, 21). Rat proteins in
pGEX-KG, pGEX-1, and pGEX-2T expression vector (Amersham Pharmacia
Biotech) encoding for thrombin-cleavable GST fusion proteins were as
follows: GST-syntaxin 1A (1-265), GST-syntaxin 1A (1-264),
GST-syntaxin 1A (180-264), GST-synaptobrevin 2 (1-94), GST-endobrevin
(1-74), GST-SNAP-25A, and GST-complexins I and II (12, 21-23).
Molecular Cloning of Recombinant Proteins--
The sequences
encoding rat complexins I and II (residues 1-134), respectively, were
amplified by PCR and subcloned into pET-15b vector via NdeI
and XhoI restriction sites resulting in fusion proteins
carrying a thrombin-cleavable amino-terminal His6 tag. GST-complexin II deletion mutants (Fig. 7) were generated by PCR and
subcloning into pGEX-KG vector via EcoRI and
BamHI restriction sites with a thrombin-cleavable
NH2-terminal GST tag. The correct sequence of all mutants
was confirmed by DNA sequencing.
SNAP-29 from rat (AF035822) was amplified by PCR using primers based on
the published GS-32 sequence from rat (24). cDNA from rat lung and
kidney (Stratagene) was used as template. The PCR products were
subcloned into pBS vector (Stratagene) and sequenced. All constructs
derived from the two different tissues were identical (GenBankTM accession no. AF260577). However, comparison
with the published GS-32 sequence revealed four nucleotide
discrepancies (c109g, t
153ca, c162-, t194c) resulting in two amino
acid exchanges (P37A, F65S) and two frameshifts resulting in three
amino acid exchanges (G52R, P53A, S54E). Comparison of the rat sequence
with human SNAP-29 (AF115436) and mouse expressed sequence tags
(e.g. AA388177, AA270049, and AA388158) further suggests
that the sequence determined here is accurate: Ala37
corresponds to Ala in human SNAP-29, and Arg-Ala-Glu in positions 52-54 are identical to the corresponding residues in human SNAP-29 and
in the mouse expressed sequence tags. The sequence encoding for
full-length SNAP-29 from rat was subcloned into pGEX-KG via BamHI and XhoI restriction sites, resulting in a
GST fusion protein.
Chimeras of rat syntaxins were generated using the overlapping primer
method by Higuchi (25) and subcloned into pET-28a, resulting in the
following chimeras (see Fig. 10): Syx 1/4, syntaxin 1A
(1-213)/syntaxin 4 (222-233)/syntaxin 1A (226-262); and Syx 4/1,
syntaxin 4-(1-221)/syntaxin 1A-(214-225)/syntaxin 4 (234-258). Sequencing of all DNAs revealed a difference from the published sequence of syntaxin 4 in a single amino acid (T216S) (26). Human and
mouse syntaxin 4 contain a serine in this position. Furthermore,
Ser216 is conserved between rat syntaxins 1, 2, and 3, suggesting that this discrepancy is probably due to a sequencing error.
Protein Expression and Purification--
All recombinant
proteins were expressed in E. coli BL21 (DE3) cells
according to standard protocols with the exception of GST-complexin I
for NMR studies. For this purpose cells were grown at 37 °C in M9
minimal media with 4 g/liter glucose, 1 g/liter NH4Cl, 1 mM MgSO4, and 50 µg/ml ampicillin. Uniform
15N and 13C labeling was achieved using
15NH4Cl and
[13C6]glucose (Isotec) as the sole nitrogen
and carbon sources, respectively. Cells were induced at optical density
0.6 with 0.8 mM
isopropyl-1-thio-
-D-galactopyranoside. His6-tagged proteins were affinity-purified using
Ni2+-NTA-agarose (Qiagen) and GST fusion proteins by
glutathione-Sepharose (Amersham Pharmacia Biotech). GST-complexin II
deletion mutants (Fig. 7) remained attached to glutathione-Sepharose.
Usually the tags were cleaved by thrombin after elution from the beads.
However, if used for precipitation in binding experiments (see below), tags remained attached to the proteins. Proteins containing
transmembrane regions (synaptobrevin-(1-116) and syntaxin-(183-288))
were eluted from the matrix and dialyzed against standard buffer
containing 1.5% sodium cholate. All other proteins were purified by
ion exchange chromatography on Mono-Q or Mono-S columns (Amersham
Pharmacia Biotech) after elution from the affinity matrix. For NMR
experiments, labeled complexin I without tag was buffer exchanged into
60 mM phosphate, 2 mM DTT, 0.5 mM
EDTA, pH 6.1 (9:1 H2O/D2O). For binding experiments using 1H-15N HSQC spectra, syntaxin
(residues 1-264 and 180-264) and the "midi core complex"
(synaptobrevin (1-96), syntaxin (180-262), and SNAP-25 (1-206)) were
dialyzed against the same buffer. All other purified proteins were
dialyzed against standard buffer (20 mM Tris, pH 7.4, 100 mM NaCl, 1 mM DTT, 1 mM EDTA).
All SNARE complexes were purified using Mono-Q column after overnight
assembly of the purified monomers (10, 21). For technical reasons,
constructs for syntaxin 1A and SNAP-25A derived from different
expression vectors were used to assemble ternary complexes: syntaxin
(1-262, pET-28a), SNAP-25 (pET-28a) (Fig. 4A); syntaxin
(1-265, pGEX-2T), SNAP-25 (pHO-2d) (Fig. 4B); syntaxin (1-265, pHO-2c), SNAP-25 (pHO-2d) (Fig. 5). No differences in structural and binding properties were observed. In addition, since it
was not possible to separate the GST moiety from the thrombin cleaved
GST-SNAP-29 fusion protein, GST-SNAP-29 was used to assemble the mixed
complex containing SNAP-29. The minimal core complex consists of
synaptobrevin (1-96), syntaxin (180-262), SNAP-25 (1-83), and
SNAP-25 (120-206) (10). Minimal core complex with bound complexin was
assembled in excess amounts of complexin II and purified by size
exclusion chromatography using a Superdex 200 HiLoad 16/60 column
(Amersham Pharmacia Biotech).
All protein concentrations were determined by the Bradford assay
(27).
NMR Spectroscopy--
All NMR spectra were acquired at 25 °C
on a Varian Unity 500 spectrometer, except the
1H-15N HSQC spectra used in the binding
experiments of complexin to the midi core complex, which were acquired
on a Varian INOVA 600 spectrometer. 1H-15N HSQC
experiments were acquired using spectral widths of 7600 and 2000 Hz in
the 1H and 15N dimensions, respectively. Data
sets consisted of 2 × 100 FIDs of 768 complex points each and
were zero filled to yield matrices of 512 × 512 real points after
Fourier transformation and removal of the aliphatic part of the
spectrum. The numer of transients per FID was adjusted to yield total
acquisition times of 0.5-36 h, depending on the protein concentration.
Sequential assignments were obtained from a series of three-dimensional
pulse field gradient-enhanced 15N-edited and triple
resonance experiments using 15N-labeled (1 mM)
and 15N,13C-labeled (0.5 mM)
complexin samples, respectively. All experiments incorporate water
flip-back pulses and sensitivity enhancement in the 15N
dimension whenever amide proton resonances are observed in the F3
dimension (28-30). The spectral widths and number of complex points in
the F3, F2, and F1 dimensions, with the number of scans per FID and the
total measurement time, indicated in parentheses, were:
1H-15N TOCSY-HSQC, 6800 × 1070 × 4500 Hz, 512 × 42 × 124 (8 scans, 50 h);
1H-15N NOESY-HSQC, 6800 × 1070 × 4500 Hz, 512 × 40 × 124 (8 scans, 53 h); HNCO,
7600 × 1070 × 1620 Hz, 512 × 26 × 80 (8 scans,
18 h); HNCACB, 7600 × 1070 × 7650 Hz, 512 × 26 × 32 (48 scans, 46 h); (H)C(CO)NH-TOCSY, 7600 × 1070 × 7650 Hz, 512 × 26 × 60 (16 scans, 32 h);
(H)CBCACO(CA)HA, 4000 × 1620 × 7650 Hz, 256 × 64 × 54 (16 scans, 61 h). The mixing times were 45 ms, 120 ms and 18 ms for the TOCSY-HSQC, NOESY-HSQC, and (H)C(CO)NH-TOCSY experiments, respectively. Linear prediction was used to double the number of points
in the F2 dimension of all spectra. After zero filling, Fourier
transformation, and removal of the aliphatic half of the F3 dimension
for all spectra except (H)CBCACO(CA)HA, matrices of 512 × 128 × 256 points were obtained.
Binding of Complexins to SNAREs and SNARE Complexes--
For the
binding assays, purified recombinant proteins or preformed SNARE
complexes were used that carried either a His6 tag or a GST
tag, or were unmodified. In some experiments, rat brain cytosol
(obtained by subjecting a homogenate, generated in 4 mM Hepes-NaOH, pH 7.3, 320 mM sucrose, to centrifugation at
12,000 × gav (Fig. 4B) or
90,000 × gav (Fig. 9C)) was
used as a source of native complexins. Unless indicated otherwise,
binding experiments were carried out in incubation buffer (20 mM Tris, pH 7.4, 100 mM NaCl, 1 mM
DTT, and 0.1% (v/v) Triton X-100). The incubation buffer was
complemented with either 0.1% (w/v) bovine serum albumin and 1 mM EDTA (GST fusion proteins) or 20 mM
imidazole (His6 fusion proteins). Incubations were
performed between 1 and 1.5 h at room temperature on a rotator.
For immunoprecipitations, anti-synaptobrevin antibody (Cl 69.1; Ref.
31) was then added for 1 h at 4 °C. Complexes were isolated by
affinity adsorption, using glutathione-Sepharose beads,
Ni2+-NTA-agarose, or Protein A-Sepharose (Amersham
Pharmacia Biotech) for GST fusion proteins, His6 fusion
proteins, and immunoprecipitations, respectively. Bead incubation was
usually approximately 1 h. The beads were then washed four or five
times in incubation buffer, except that Triton X-100 and bovine serum
albumin were omitted and imidazole was lowered to 8 mM.
Beads were analyzed by SDS-PAGE and Coomassie Blue staining. Where
indicated, complexins were detected by immunoblotting using polyclonal
antibody 942 (Synaptic Systems, Göttingen, Germany; 1:2000)
against the COOH terminus of complexin I and II (amino acid residues
122-134, rat sequence) and enhanced chemiluminescence (ECL, NEN Life
Science Products) on a Fujifilm LAS-1000 system.
Binding to SNAREs Reconstituted in
Proteoliposomes--
Proteoliposomes with reconstituted full-length
synaptobrevin or ternary complex with transmembrane regions were
prepared as previously described (20). Liposomes adjusted to 0.4 µM each of synaptobrevin 2 and ternary complex,
respectively, were each incubated with 0.8 µM complexin I
or II or both for 1 h at room temperature in standard buffer.
Liposomes were then immunoisolated by incubating in monoclonal antibody
Cl 69.1 (5 µl of ascites) for 1 h at room temperature on a
rotator, followed addition of Protein A-Sepharose and an additional
incubation for 1 h. After sedimentation and removal of the
supernatant containing unbound material, the beads were washed four
times with 0.5% (v/v) Triton X-100-containing standard buffer. Fifty
percent of the Sepharose-bound material were analyzed by immunoblot
using antibody 942.
Other Methods--
For limited proteolysis, purified complexes
(8 µM) were incubated in 1% (w/w) proteinase K at
25 °C in standard buffer. At the indicated times, proteolysis was
stopped by adding sample buffer without SDS containing 2 mM
phenylmethylsulfonyl fluoride and chilling on ice. All samples were
analyzed by nondenaturing PAGE and Coomassie Blue staining.
Masses of the complexin II-fragments obtained by limited proteolysis
were determined by matrix-assisted laser desorption ionization-time of
flight mass spectrometry (Perseptive). For NH2-terminal
amino acid sequencing, 1-4 µg of complexin fragment were transferred to polyvinylidene difluoride membrane by blotting and sequenced by a
Protein Sequencer 810 (Knauer).
Multi-angle laser light scattering (MALLS) and circular dichroism (CD)
spectroscopy were performed as described earlier (21).
SDS-PAGE was carried out as described (32). SDS sample buffer (final
concentrations: 62.5 mM Tris, pH 6.8, 3% SDS, 10%
glycerol, 3.3%
-mercaptoethanol) was added, and samples were
incubated at room temperature (not heated) or 95 °C (heated) for 5 min before separation on 15% polyacrylamide gels. Nondenaturing gels
were prepared and run as described (7).
 |
RESULTS |
Complexin Contains a Conserved
-Helical Middle Region but Lacks
a Tertiary Structure--
In vertebrates, two isoforms of complexin
were described that differ only by a few amino acid substitutions and a
very high degree of homology was found between distant vertebrate
species. Since functionally important domains are usually more highly
conserved than flanking regions, we performed data base searches to
identify invertebrate orthologs of complexins, and to compare them with the vertebrate sequences. As shown in Fig.
1, sequences probably representing
complexins were found both in Drosophila melanogaster (full-length) and Caenorhabditis elegans (partial). Sequence
alignments revealed a high degree of overall homology between
vertebrates and invertebrates, which, however, is still significantly
lower than among vertebrates. The highest degree of conservation was detected in a region at the middle of the sequence spanning
approximately residues 34-77 (numbering according to the rat
sequence).

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 1.
Complexins are highly conserved as revealed
by sequence data base analysis. Figure shows sequence comparison
of complexins from Rattus norvegicus (RN),
Narke japonica (NJ), D. melanogaster
(DM), and C. elegans (CE). Sequence
alignment was performed using the programs ClustalW and Boxshade.
Identical and conserved amino acids are darkly and
lightly shaded, respectively. The C. elegans
sequence may be incomplete. No additional complexin orthologs were
found in C. elegans and D. melanogaster.
GenBankTM accession numbers for the proteins are as
follows: Cpx I, RN, U35098; Cpx II,
RN, U35099; Syn 1A, NJ, AB004243;
Syn 2, NJ, AB004245. The C. elegans
(accession no. Z77133, gene KO3A11.2) and D. melanogaster sequences (accession no. AF260578) have been
submitted to GenBankTM. Cpx, complexin;
Syn, synaphin.
|
|
The structure of purified recombinant rat complexin I in solution was
analyzed using nuclear magnetic resonance (NMR) and circular dichroism
(CD) spectroscopy. The 1H-15N heteronuclear
single quantum correlation (HSQC) spectrum of complexin (Fig.
2) exhibits a poor dispersion of
1H chemical shifts that suggests a lack of tertiary
structure. In contrast, the CD spectrum of complexin contains a double
minimum at 206 and 222 nm (data not shown), and is characteristic for a
mixture of
-helical and random coil conformations. To locate the
-helical region, we used multidimensional NMR techniques. The severe
overlap of the 1H-15N HSQC spectrum hindered
assignment of the complexin 1H, 15N, and
13C resonances. A combination of triple resonance spectra
and three-dimensional 15N-edited TOCSY-HSQC and NOESY-HSQC
experiments allowed us to obtain nearly complete (97.1%) sequential
assignments (Fig. 2).

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 2.
1H-15N HSQC spectrum
of complexin. The spectrum was acquired at 500 MHz and 25 °C
using a solution of 1 mM 15N-labeled complexin
I in 60 mM phosphate buffer (pH 6.1). The most crowded
regions of the spectrum are expanded in the insets.
Cross-peak assignments are indicated by one-letter amino
acid codes and residue numbers. An asterisk (*)
indicates cross-peaks corresponding to residues from an
NH2-terminal sequence arising from the expression vector
used. N, Qsc indicates cross-peaks from Asn and
Gln side chains.
|
|
The observation of numerous sequential NH/NH and medium range nuclear
Overhauser effects (NOEs) (Fig.
3A) confirmed that a substantial part of the complexin sequence forms an
-helical structure. The medium range NOEs are most abundant between residues 29 and 86, indicating that the
-helical content is highest in this
region. This conclusion is corroborated and refined by plots of H
and C
conformational shifts versus the amino acid
sequence of complexin (Fig. 3B, solid
diamonds). These plots show that a stable
-helix is
formed from residues 29-64, whereas residues 65-86 contain a
substantial but lower population of
-helix. The
-helical region
overlaps with the conserved middle region identified by sequence
comparison (Fig. 1). Other regions of the molecule may sample helical
conformations only occasionally. Overall, the NMR results indicate that
complexin is 35-40%
-helical.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 3.
Complexin contains a central
-helix. A, summary of sequential
and medium range N and NN NOEs observed in the 3D
1H-15N NOESY-HSQC spectrum of
15N-labeled complexin I. Solid and
dashed lines indicate well resolved and
overlapped NOEs, respectively. The thickness of the
lines reflects the NOE intensity. B, plots of
H and C conformational shifts ( ) as a function of the
complexin sequence. Solid diamonds indicate the
experimental values calculated as differences between the observed
chemical shifts and the random coil values described in the
BioMagResBank. Open diamonds show the
conformational shifts predicted with the program AGADIR (42), an
algorithm based on the helix/coil transition theory that has been
proven to be useful to predict conformational shifts and populations of
secondary structure in peptides at the residue level. Note that the
conformational shifts expected for an -helical conformation are
negative for H and positive for C .
|
|
A detailed analysis of all NOE data failed to reveal any long range
NOEs, confirming the absence of tertiary structure. The presence of a
stable
-helix in residues 29-64 is surprising since formation of
stable secondary structure in the absence of tertiary interactions is
unusual. However, the presence of an
-helix in this region agrees
with theoretical predictions (Fig. 3B). Furthermore, the
-helix is not stabilized by oligomerization. Complexin is monomeric
when analyzed by size exclusion chromatography combined with MALLS
(data not shown); furthermore, the 1H-15N HSQC
spectrum does not change over a wide concentration range (0.01-2
mM).
The
-Helical Middle Region of Complexin Stoichiometrically Binds
to the SNARE Core Complex--
Next we investigated the binding of
complexin to individual SNAREs and SNARE complexes using purified
recombinant proteins and protein fragments. Unless stated otherwise,
all SNAREs were expressed in bacteria without their transmembrane
region. First, the binding of syntaxin 1, SNAP-25, synaptobrevin, and
of preassembled ternary SNARE complex to His6-tagged
complexin II was investigated. Only the ternary complex associated with
complexin in significant amounts under our experimental conditions
(Fig. 4A). A similar result
was obtained when GST-tagged SNAREs and GST-tagged ternary complex were
incubated with rat brain cytosol as a source of native complexins (Fig.
4B). Both complexin I and complexin II bound to the ternary
complex, whereas no binding was observed to monomeric SNAREs. Together,
these results agree with previous findings, which showed that
complexins preferentially bind to assembled SNARE complexes (12).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 4.
Complexins bind preferentially to the ternary
SNARE complex. A, purified recombinant SNAREs and
ternary complex (4 µM) were incubated with
His6-tagged complexin II (3 µM). Complexin
was precipitated with Ni2+-NTA-agarose. Bound material was
analyzed by SDS-PAGE and Coomassie Blue staining. In contrast to the
standard protocol, the incubation buffer contained 1 mM
phenylmethylsulfonyl fluoride, and DTT was omitted from the washing
buffer. B, purified recombinant SNAREs (containing GST tags)
and ternary complex (containing GST-syntaxin, 0.75 µM
each) were incubated with rat brain cytosol (2 mg/ml, as a source of
native complexins) followed by precipitation with
glutathione-Sepharose. Bound complexins were analyzed by SDS-PAGE and
immunoblotting. As a control, 40 µg of cytosol were loaded.
C, binding of recombinant complexins to proteoliposomes that
were reconstituted with either synaptobrevin or ternary complex. Bound
complexins were detected by immunoblot. Note that, in the presence of
equal amounts of both complexins, preferential binding of complexin I
is observed (right lane). Additional
immunodetection with Cl 69.1 revealed that equal amounts of
synaptobrevin and ternary complex were precipitated (data not shown).
Syb, synaptobrevin; Syx, syntaxin; TC,
ternary complex.
|
|
To confirm that complexin also binds to the ternary complex when it is
incorporated into a membrane, purified synaptobrevin and ternary
complex (including transmembrane regions) were reconstituted into
proteoliposomes by detergent removal. Binding of both complexin I and
complexin II was determined by immunoisolation of the proteoliposomes with the aid of an anti-synaptobrevin monoclonal antibody. As shown in
Fig. 4C, liposomes containing the ternary complex bound each
of the complexins while no binding was observed to
synaptobrevin-containing liposomes. When equal amounts of both
complexin isoforms were included in the assay, preferential binding of
complexin I was observed.
Next, we measured the stoichiometry of complexin binding. Preliminary
experiments revealed that the association between complexin and the
ternary complex is sufficiently stable to allow for its separation from
both free ternary complex and the uncomplexed proteins by means
of nondenaturing PAGE. Increasing concentrations of complexin II were
incubated with a fixed concentration of purified ternary complex. As
shown in Fig. 5A, a gradual
shift from free ternary complex to complexin-bound ternary complex was
observed until all free ternary complex disappeared. When more
complexin was added, no further binding was observed, and unbound
complexin accumulated. At equal concentrations of complexin and ternary complex, only bound complexin was detectable. We conclude that the
stoichiometry between complexin and the ternary complex is 1:1.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Complexin forms a 1:1 complex with the
ternary SNARE complex and with its minimal core. The various
complexes were separated by nondenaturing PAGE from each other and from
free complexin. Increasing amounts of complexin II (concentrations as
indicated) were added to a constant amount of ternary complex
(A) or of the minimal core complex (B) and
incubated in standard buffer at 4 °C overnight or at room
temperature for 1 h, respectively. Proteins were visualized by
Coomassie Blue staining. MC, minimal core complex.
|
|
As discussed in the Introduction, assembly of SNAREs into core
complexes is confined to a region which encompasses the SNARE motifs.
We have shown previously that a minimal core complex can be formed from
recombinant fragments that has similar properties to the non-truncated
complex with respect to assembly, disassembly, and stability (10).
Since complexin binds to the ternary complex with strong preference
over the individual proteins, we examined whether binding is confined
to the minimal core complex. Minimal core complex was generated and
purified as described previously (10), and complexin binding was
analyzed as described above. As shown in Fig. 5B, complexin
bound to this minimal complex with similar efficiency and with a 1:1 stoichiometry.
The stability of complexin binding to the minimal core prompted us to
purify this complex for further structural investigations. After
purification, the complex was subjected to time-dependent proteolysis using proteinase K, a protease with broad substrate specificity, followed by analysis with non-denaturing PAGE. As shown in
Fig. 6, a gradual shift of the complex to
higher mobilities was observed. Since the minimal core is largely
resistant to proteolysis (Fig. 6; see also Refs. 10 and 33), this shift
is mostly due to truncation of complexin. SDS-PAGE revealed several
complexin fragments that were further analyzed by matrix-assisted laser desorption ionization-time of flight mass spectrometry and by NH2-terminal sequencing. Proteolysis was first observed at
the NH2 terminus, resulting in a peptide containing
residues 21-134. When the incubation time was extended, progressive
COOH-terminal truncations were observed (including fragments containing
residues 21-116), while no further shortening of the NH2
terminus was detected.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 6.
Limited proteolysis of the minimal core
complex with bound complexin. The major complexin fragments
generated during proteolysis remain bound to the minimal core complex.
Digests of complexin II bound to the minimal core complex were shifted
in comparison to parallel digests of the minimal core complex when
analyzed by nondenaturing PAGE and Coomassie Blue staining.
|
|
To further define the complexin binding region, we generated a series
of deletion mutants of complexin II using the proteolysis experiment as
a guide. As shown in Fig. 7, progressive
deletion at both COOH- and NH2-terminal ends did not
abolish binding, with the smallest binding fragment encompassing
residues 41-97. In contrast, no binding was observed when the protein
was "cut" in the middle, i.e. with the COOH- and
NH2-terminal halves of complexin. In addition, no binding
was observed when both fragments were added together (data not
shown).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 7.
Mapping of the binding domain of complexin by
deletion mutagenesis. A series of truncated GST-complexin II
fusion proteins was immobilized to glutathione-Sepharose beads
(approximately 8 µM each) and incubated with purified
minimal core complex (13 µM). After washing of the beads,
bead-bound material was analyzed by SDS-PAGE and Coomassie Blue
staining. All samples were boiled prior to separation to dissociate the
SNARE components of the minimal core complex. Note that all complexin
fragments bound to the minimal core complex except for fragments 1-69
and 70-134.
|
|
The data described so far suggest that the binding region of complexin
corresponds approximately to the conserved
-helical region
characterized above. To confirm and extend these findings, we used NMR
spectroscopy. The changes in the 1H-15N HSQC
spectrum of a 15N-labeled protein caused by binding to an
unlabeled protein can be used to map the region of the labeled protein
involved in the interaction (34). For a 15N-labeled protein
lacking a tertiary structure such as complexin, it is expected that
interaction with another protein will result in severe broadening of
the 1H-15N HSQC cross-peaks from the region
involved in binding due to the resulting increase in correlation time.
Regions not involved in binding are expected to retain internal
motions, and their 1H-15N HSQC cross-peaks
should remain largely unaffected (35).
We first recorded 1H-15N HSQC spectra of
15N-labeled complexin I in the absence and presence of
unlabeled cytoplasmic region of syntaxin 1A (residues 1-264). No
spectral changes were observed in these experiments (data not shown),
in good agreement with the biochemical observations. Since binding
could be hindered by the intramolecular interaction of the
NH2-terminal domain of syntaxin with its COOH-terminal
SNARE motif (23), we performed additional
1H-15N HSQC experiments using
15N-labeled complexin and an unlabeled fragment of syntaxin
(residues 180-264) containing only the SNARE motif. Addition of this
fragment caused broadening of a few 1H-15N HSQC
cross-peaks from complexin (Fig.
8A). However, the residues corresponding to these cross-peaks are not clustered in any specific region but instead are spread throughout the complexin sequence. These
results indicate that the observed interaction is not specific.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 8.
Mapping of the binding domain of complexin by
NMR: complexin binds to the core complex via its central
-helix. 1H-15N HSQC
spectra of isolated 15N-complexin I (single thick
contours) superimposed with 1H-15N HSQC
spectra acquired on identical samples after addition of one equivalent
of syntaxin SNARE motif (residues 180-264) (A) or midi core
complex (B) (single thin contours). The
experiments were acquired at 500 MHz (A) or 600 MHz
(B) under the conditions described in Fig. 2, except that
the concentration of all proteins was 90 µM
(A) or 40 µM (B). Note that some
cross-peaks from NH groups in fast exchange with the solvent are
observed only at 600 MHz (e.g. those from Arg side chains on
the right side of the spectrum). At the bottom,
the sequence of complexin I is shown summarizing the spectral changes
observed upon addition of the midi core complex (spectra shown in
B). Boxed residues with a black
background correspond to cross-peaks that broaden beyond
detection, and underlined residues correspond to
cross-peaks with moderate broadening or slight shifts. For some
cross-peaks, spectral changes cannot be assessed due to severe overlap
and the corresponding residues are indicated by open
boxes. All experiments were performed at protein
concentrations below 100 µM to minimize
aggregation.
|
|
Next we acquired 1H-15N HSQC spectra of
15N-labeled complexin in the presence of unlabeled ternary
complex containing a NH2-terminally truncated version of
syntaxin 1A (midi core complex, syntaxin residues 180-262). About half
of the 1H-15N HSQC cross-peaks of complexin
were broadened beyond detection, and several cross-peaks exhibited
partial broadening and/or slight shifts (Fig. 8B). The
spectral changes are summarized on the sequence of complexin at the
bottom of Fig. 8. All cross-peaks that broadened beyond
detection correspond to the region encompassing residues 26-83, which
approximately coincides with the helical region at the center of the
complexin sequence. Furthermore, moderate perturbations (broadening
and/or shifts) were observed in the NH2-terminal region (residues 1-25) and the very COOH terminus (residues 121-134). These
perturbations most likely arise from nonspecific binding modes.
However, it is also possible that the NH2- and
COOH-terminal regions of complexin may be involved in direct or
indirect interactions with the core complex in the presence of
additional components of the exocytotic machinery.
Complexin Binding Is Sensitive to Exchange of Syntaxin and
Synaptobrevin--
As discussed above, the core domain of the SNARE
complex consists of a bundle of four twisted
-helices that are
connected by leucine zipper-like layers of interacting hydrophobic
amino acids in the center of the bundle. Mapping SNARE sequences on the
crystal structure revealed that the interacting amino acids are more
conserved than the residues exposed on the surface (3), explaining why
SNARE complexes form promiscuously between different SNARE proteins
(21, 36). However, substitution of one SNARE for another will usually
result in a profound alteration of the surface pattern, which thus
distinguishes different SNARE complexes from each other. Since
complexin binds to the surface of the assembled core domain and most
likely does not have access to its hydrophobic core, it is conceivable
that complexin binding is more sensitive to SNARE substitution than
SNARE complex formation.
To examine whether substitution of SNAREs affects binding of
complexins, we generated mixed SNARE complexes in which one of the
neuronal SNAREs was substituted by a different family member. All mixed
complexes were purified, are stable, and can be disassembled by the
ATPase NSF (21, 36). As shown in Fig.
9A, replacement of
synaptobrevin with the endosomal relative endobrevin abolished binding
of complexins. In contrast, binding was largely preserved when SNAP-25
was replaced by its distant relative SNAP-29 (Fig. 9B).
Since SNAP-25 and SNAP-29 are only 19.9% similar to each other
(Clustal method with PAM250 residue weight table), and the conserved
residues are mostly confined to the hydrophobic core of the SNARE
complex, this result indicates that the SNAP-25 side chains contribute
less to complexin binding. Finally, we replaced syntaxin 1 with
syntaxins 2, 3, and 4. Complexins bound with equal efficiency to the
syntaxin 3-containing complexes (Fig. 9C), which agrees with
previous observations suggesting an association of complexin with
syntaxin 3, synaptobrevin, and SNAP-25 in the retina (37). Replacement
by syntaxin 2 reduced binding, with a preference for complexin II,
whereas replacement by syntaxin 4 abolished binding.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 9.
Substitution of syntaxin 1 and synaptobrevin
2 but not of SNAP-25 abolishes binding of complexins to ternary SNARE
complexes. The following substitutions were carried out:
endobrevin (Eb) for synaptobrevin 2 (A), SNAP-29
for SNAP-25 (B), and syntaxins 2-4 for syntaxin 1A
(C). In each of the SNARE complexes at least one of the
proteins carried a His6 tag. The complexes (1.5 µM each) were incubated with recombinant complexins (2.0 µM in A and B, 1.5 µM
in C). In panel C (bottom),
rat brain cytosol (2 mg/ml) was used instead. After isolation by
Ni2+-NTA-agarose beads, bound complexins were detected by
SDS-PAGE followed by Coomassie Blue staining (A,
B, and C (top panel)) or
immunoblotting (C, bottom panel). Note
that no binding is observed in complexes containing endobrevin or
syntaxin 4. For A and B, incubation buffer with 1 mM phenylmethylsulfonyl fluoride was used (see standard
protocol). For C (top panel),
incubation buffer contained 120 mM NaCl, but no DTT.
Incubation with native complexins (C, bottom
panel) was carried out at 4 °C for 2 h. For all
experiments, washing buffer without DTT was used and samples were
heated prior to electrophoresis.
|
|
In contrast to synaptobrevin/endobrevin and SNAP-25/SNAP-29, the SNARE
motifs of syntaxins 1-4 display a relatively high degree of homology.
To narrow down the sequence responsible for the observed differences in
complexin binding, we compared syntaxins 1 and syntaxin 4 in order to
identify the regions with the lowest degree of homology between the
surface-exposed residues. The most conspicuous stretch includes
residues 214-225 (numbering of syntaxin 1). To test whether this
stretch is involved in complexin binding, we generated chimeric
proteins by swapping these stretches of 12 residues between syntaxin 1 and syntaxin 4. The chimeras were then used to form ternary complexes
with synaptobrevin and SNAP-25 that were purified and used in complexin
binding assays. As shown in Fig. 10,
the complex formed with the chimera of syntaxin 1 containing the
stretch of syntaxin 4 bound significantly less complexins than the
unmodified complex. Conversely, the syntaxin 4 chimera containing the
stretch of syntaxin 1 exhibited partially restored complexin binding.
These findings show that this stretch plays a key role in defining the
binding site for complexins, although it is most probable that flanking
regions of the molecule are also involved.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 10.
Exchange of a 12-amino acid segment
between syntaxin 1 and syntaxin 4 confers complexin binding to syntaxin
4-containing, and diminishes binding to syntaxin 1-containing SNARE
complexes. A, sequence alignment of rat syntaxins 1A,
2, 3, and 4 showing the stretch used in the exchange. B,
position of the exchanged segment (dark red,
between 4 and 0 layer) in the crystal structure of the neuronal core
complex (8). Red, syntaxin 1A; blue,
synaptobrevin 2; gray, NH2- (SN1) and
COOH-terminal (SN2) fragments of SNAP-25. C, binding of
complexins (1.5 µM) to ternary complex (1.5 µM) containing wild type syntaxin 1A, syntaxin
1/4-, syntaxin 4/1-chimera, and syntaxin 4. Complexes were isolated by
immunoprecipitation (see "Experimental Procedures") and
analyzed for complexins I and II by SDS-PAGE and Coomassie Blue
staining. Controls documented that equal amounts of ternary complex
were recovered in each immunoprecipitate (data not shown). Incubation
and washing steps were carried out in buffer as described for
His6 and GST fusion proteins, respectively.
|
|
Complexin Does Not Affect Disassembly of the SNARE Complex--
In
the final series of experiments, we investigated whether complexin has
an influence on the disassembly of preformed SNARE complexes by NSF and
-SNAP. The minimal core of the neuronal SNARE complex was purified
either with or without bound complexin II. For disassembly, purified
-SNAP and NSF were added in the presence of ATP. Since the minimal
core complex is stable during SDS-PAGE, the appearance of the monomeric
SNARE components is indicative of disassembly. As shown in Fig.
11A, disassembly was observed independently of whether complexin was bound or not. The
minimal core complex was also disassembled when complexin was added in
a 20-fold excess over
-SNAP, even when the incubation time was
reduced to 5 min (Fig. 11B). Furthermore, no influence of
complexin on disassembly was observed when the non-truncated versions
of the SNARE proteins were used (data not shown). We also performed
preliminary experiments on isolated synaptic vesicles to explore
whether complexin has an effect on disassembly of native SNARE
complexes. However, no changes were found in the presence of complexins
(data not shown).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 11.
Complexin does not affect disassembly of the
minimal core complex. A, purified minimal core complex
(2.4 µM) and minimal core complex with bound complexin II
(1.9 µM), respectively, were disassembled by addition of
equal concentrations of NSF and a 14-fold excess of -SNAP, 2 mM MgCl2, and 2.5 mM ATP in 20 mM Tris, pH 7.4, 100 mM NaCl, 1 mM
DTT for 30 min at 30 °C. The reaction was stopped by adding SDS
sample buffer. As a control, the ATPase activity of NSF was abolished
by replacing MgCl2 with 10 mM EDTA. All samples
were analyzed by SDS-PAGE and Coomassie Blue staining. Unless heated,
the minimal core complex (MC) runs as a single band of 34 kDa (left lane) and thus can be separated from
the monomeric SNARE components generated during disassembly.
B, disassembly is not affected when complexin is present in
a 20-fold excess over -SNAP. Purified minimal core complex (0.63 µM) was preincubated for 15 min at room temperature with
108 µM complexin II and disassembled as above by addition
of 1.2 µM NSF, 5.4 µM -SNAP, 4 mM MgCl2, and 2.5 mM ATP for the
indicated times. Disassembly was measured as in A, except
that the appearance of synaptobrevin and SNAP-25-(1-83) was monitored
by immunoblotting using monoclonal antibodies Cl 69.1 and Cl 71.1 (43),
respectively.
|
|
 |
DISCUSSION |
Complexin is a small and hydrophilic protein that was identified
by its ability to bind to the neuronal SNARE complex (12, 13). In this
study, we have used a combination of approaches to characterize this
interaction in detail. Our results show that complexin binds
stoichiometrically to the ternary SNARE complex, whereas it exhibits no
binding to the individual SNAREs. Free complexin lacks a tertiary
structure but contains a conserved
-helical domain at the center of
its sequence which mediates binding. Furthermore, complexin is able to
discriminate between different SNARE complexes. Substitution of
individual SNAREs and site-directed mutagenesis suggest that complexin
binds predominantly to the groove formed by syntaxin and synaptobrevin
at the surface of the core complex.
The central
-helix of complexin was shown to be responsible for
binding to the SNARE complex by means of three independent approaches:
limited proteolysis, deletion mutagenesis, and NMR spectroscopy. Thus,
the binding region of complexin corresponds to the structured part of
the molecule. Furthermore, we were unable to detect signs for major
conformational changes of either complexin or the core complex during
the binding reaction. These features differ from the assembly of SNARE
motifs that are mostly unstructured as monomers and that undergo
massive structural changes upon complex formation (6, 7). The binding
domain of complexin contains more than 60% charged residues. Since the
surface of the neuronal core complex is also highly polar (8), it is
likely that polar and electrostatic interactions are primarily
responsible for binding.
Although the precise nature of complexin binding to the core complex
remains to be established, several conclusions can be drawn from our
results. First, the central region of the core complex is critical for
complexin binding, as shown by site-directed mutagenesis of syntaxin 1 (Fig. 10). Second, the membrane-proximal region of the core complex
does not appear to be involved because complexes formed from
COOH-terminally truncated SNAREs (e.g. by clostridial
neurotoxins (Ref. 38)) bind with comparable
efficiency.3 Third, syntaxin
1 and synaptobrevin are more important for complexin binding than
SNAP-25. Since, in the crystal structure of the neuronal SNARE complex,
the helices of syntaxin and synaptobrevin form one of the grooves
extending through the length of the bundle, it is possible that the
helix of complexin aligns along this groove during binding.
One of our most interesting findings shows that complexin is capable of
distinguishing between core complexes formed from different sets of
SNAREs. Such complexes are predicted to differ much more in their
surface patterns than in their core interactions (3). Indeed, in
vitro studies have shown that SNAREs form core complexes rather
indiscriminately (21, 36), and consequently one must look elsewhere for
an explanation for the intracellular specificity of SNARE interactions
and their regulation. Although no other relatives of complexin have
been identified so far, it is possible that other related proteins
exist that bind with comparable selectivity to different SNARE complexes.
How does complexin regulate the functioning of neuronal SNAREs?
Although this question cannot be answered at present, some important
features are beginning to emerge. First, it is unlikely that complexin
regulates pools of individual SNAREs since it does not bind with high
affinity to any of the monomeric SNAREs, unlike, for instance, munc-18
(39). Second, we need to consider whether complexin regulates
disassembly of the SNARE complex by
-SNAP and NSF. In our hands,
complexin was unable to inhibit or slow the disassembly of fully formed
SNARE complexes with or without transmembrane regions, arguing against
such a role. It should be borne in mind, however, that
-SNAP was
shown earlier to displace bound complexin from the SNARE complex (12).
Disassembly creates SNARE monomers that do not bind complexin,
effectively abolishing the binding site of the protein. Thus, although
it is less likely, we cannot discard the possibility of a more subtle,
kinetic effect of complexin on disassembly of core complexes.
Third, complexin may be involved in regulating the formation of SNARE
complexes before membrane fusion. As outlined in the Introduction,
SNARE complexes are thought to initially form trans complexes that connect the two membranes before fusion. These complexes
are probably reversible and in dynamic equilibria between loose and
tight states (40). After fusion, all SNAREs are aligned in parallel
within the same membrane in the form of relaxed cis complexes. Although complexin does bind to cis complexes, it
is attractive to speculate that complexin may assist in the formation of trans complexes, subsequently guiding them through fusion
until the relaxed cis state is reached. Indeed, complexin
may be able to "proof-read" SNARE complexes upon their initial
formation. It may stabilize cognate neuronal complexes and ignore
non-cognate complexes during their initial formation, thus contributing
to the specificity of SNARE pairing (see above). Unfortunately, there are presently no reliable assays for measuring trans
complexes; therefore, the influence of complexin on this reaction
cannot be determined. Clearly, however, the assembly of cis
complexes in vitro is not influenced by complexin because
addition of excess amounts of complexin does not affect the kinetics or
the extent of SNARE-assembly.3
Fourth, binding of complexin to trans complexes could have a
role in a phase directly preceding fusion, or in fusion itself. Several
different mechanisms can be imagined. For instance, in a recent
abstract, it was suggested that complexins may cause higher order
oligomers of SNARE complexes as might be expected to form around the
fusion pore (41). However, we were unable to observe any induced
oligomerization when the complexes were analyzed by size exclusion
chromatography followed by MALLS.3 More interesting
possibilities include a prevention of fusion pore formation. Finally,
it is conceivable that complexin binding to trans complexes
does not influence the assembly reaction directly but rather regulates
the recruitment of late acting control proteins to the fusion site such
as synaptotagmin. We hope that the data presented here will assist in
designing experiments that differentiate between these possibilities.
 |
ACKNOWLEDGEMENTS |
We thank M. Margittai for kindly providing us
with proteoliposomes and the disassembly machinery, M. Druminski for
excellent technical support on purifying native material, and in
addition all members of the Jahn laboratory for fruitful discussions.
 |
FOOTNOTES |
*
This work was supported by an Established Investigator grant
from the American Heart Association and by National Institutes of
Health Grant NS37200 (to J. R.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF260577 and AF260578.
¶
Present address: Dept. of Microbiology, University of
Illinois, Urbana, IL 61801.
**
To whom correspondence should be addressed: Dept. of Neurobiology,
Max-Planck-Institute for Biophysical Chemistry, Am Fassberg, D-37077
Göttingen, Germany.Tel.: 49-551-201-1635; Fax: 49-551-201-1639; E-mail: dfassha@mpibpc.gwdg.de.
Published, JBC Papers in Press, April 20, 2000, DOI 10.1074/jbc.M002571200
2
N. Brose, personal communication.
3
S. Pabst, R. Jahn, and D. Fasshauer, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
SNARE, soluble
N-ethylmaleimide-sensitive factor attachment protein
receptor;
CD, circular dichroism;
DTT, dithiothreitol;
FID, free
induction decay;
GST, glutathione S-transferase;
HSQC, heteronuclear single quantum correlation;
MALLS, multi-angle laser
light scattering;
NOE, nuclear Overhauser effect;
NOESY, nuclear
Overhauser effect spectroscopy;
NSF, N-ethylmaleimide-sensitive factor;
NTA, nitrilotriacetic
acid;
PAGE, polyacrylamide gel electrophoresis;
PCR, polymerase chain
reaction;
SNAP, soluble N-ethylmaleimide-sensitive factor
attachment protein;
SNAP-25, synaptosomal associated protein of 25 kDa;
SNAP-29, synaptosomal associated protein of 29 kDa;
TOCSY, total
correlation spectroscopy.
 |
REFERENCES |
| 1.
|
Rothman, J. E.
(1994)
Nature
372,
55-63
|
| 2.
|
Weimbs, T.,
Mostov, K.,
Low, S. H.,
and Hofmann, K.
(1998)
Trends Cell Biol.
8,
260-262
|
| 3.
|
Fasshauer, D.,
Sutton, R. B.,
Brunger, A. T.,
and Jahn, R.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
15781-15786
|
| 4.
|
Jahn, R.,
and Südhof, T. C.
(1999)
Annn. Rev. Biochem.
68,
863-911
|
| 5.
|
Sollner, T.,
Bennett, M. K.,
Whiteheart, S. W.,
Scheller, R. H.,
and Rothman, J. E.
(1993)
Cell
75,
409-418
|
| 6.
|
Fasshauer, D.,
Bruns, D.,
Shen, B.,
Jahn, R.,
and Brunger, A. T.
(1997)
J. Biol. Chem.
272,
4582-4590
|
| 7.
|
Fasshauer, D.,
Otto, H.,
Eliason, W. K.,
Jahn, R.,
and Brunger, A. T.
(1997)
J. Biol. Chem.
272,
28036-28041
|
| 8.
|
Sutton, R. B.,
Fasshauer, D.,
Jahn, R.,
and Brunger, A. T.
(1998)
Nature
395,
347-353
|
| 9.
|
Hayashi, T.,
McMahon, H.,
Yamasaki, S.,
Binz, T.,
Hata, Y.,
Südhof, T. C.,
and Niemann, H.
(1994)
EMBO J.
13,
5051-5061
|
| 10.
|
Fasshauer, D.,
Eliason, W. K.,
Brunger, A. T.,
and Jahn, R.
(1998)
Biochemistry
37,
10354-10362
|
| 11.
|
Hanson, P. I.,
Heuser, J. E.,
and Jahn, R.
(1997)
Curr. Opin. Neurobiol.
7,
310-315
|
| 12.
|
McMahon, H. T.,
Missler, M.,
Li, C.,
and Südhof, T. C.
(1995)
Cell
83,
111-119
|
| 13.
|
Ishizuka, T.,
Saisu, H.,
Odani, S.,
and Abe, T.
(1995)
Biochem. Biophys. Res. Commun.
213,
1107-1114
|
| 14.
|
Takahashi, S.,
Yamamoto, H.,
Matsuda, Z.,
Ogawa, M.,
Yagyu, K.,
Taniguchi, T.,
Miyata, T.,
Kaba, H.,
Higuchi, T.,
Okutani, F.,
and Fujimoto, S.
(1995)
FEBS Lett.
368,
455-460
|
| 15.
|
Ono, S.,
Baux, G.,
Sekiguchi, M.,
Fossier, P.,
Morel, N. F.,
Nihonmatsu, I.,
Hirata, K.,
Awaji, T.,
Takahashi, S.,
and Takahashi, M.
(1998)
Eur. J. Neurosci.
10,
2143-2152
|
| 16.
|
Itakura, M.,
Misawa, H.,
Sekiguchi, M.,
Takahashi, S.,
and Takahashi, M.
(1999)
Biochem. Biophys. Res. Commun.
265,
691-696
|
| 17.
|
Takahashi, S.,
Ujihara, H.,
Huang, G. Z.,
Yagyu, K.,
Sanbo, M.,
Kaba, H.,
and Yagi, T.
(1999)
Eur. J. Neurosci.
11,
2359-2366
|
| 18.
|
Bennett, M. K.,
Calakos, N.,
and Scheller, R. H.
(1992)
Science
257,
255-259
|
| 19.
|
Elferink, L. A.,
Trimble, W. S.,
and Scheller, R. H.
(1989)
J. Biol. Chem.
264,
11061-11064
|
| 20.
|
Margittai, M.,
Otto, H.,
and Jahn, R.
(1999)
FEBS Lett.
446,
40-44
|
| 21.
|
Fasshauer, D.,
Antonin, W.,
Margittai, M.,
Pabst, S.,
and Jahn, R.
(1999)
J. Biol. Chem.
274,
15440-15446
|
| 22.
|
Chapman, E. R.,
An, S.,
Barton, N.,
and Jahn, R.
(1994)
J. Biol. Chem.
269,
27427-27432
|
| 23.
|
Dulubova, I.,
Sugita, S.,
Hill, S.,
Hosaka, M.,
Fernandez, I.,
Südhof, T. C.,
and Rizo, J.
(1999)
EMBO J.
18,
4372-4382
|
| 24.
|
Wong, S. H.,
Xu, Y.,
Zhang, T.,
Griffiths, G.,
Lowe, S. L.,
Subramaniam, V. N.,
Seow, K. T.,
and Hong, W.
(1999)
Mol. Biol. Cell
10,
119-134
|
| 25.
|
Higuchi, R.,
Krummel, B.,
and Saiki, R. K.
(1988)
Nucleic Acids Res.
16,
7351-7367
|
| 26.
|
Bennett, M. K.,
Garcia-Arraras, J. E.,
Elferink, L. A.,
Peterson, K.,
Fleming, A. M.,
Hazuka, C. D.,
and Scheller, R. H.
(1993)
Cell
74,
863-873
|
| 27.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
|
| 28.
|
Kay, L. E.
(1993)
J. Am. Chem. Soc.
115,
2055-2057
|
| 29.
|
Kay, L. E.,
Guang Yi, X.,
and Yamazaki, T.
(1994)
J. Magn. Res. Ser. A
109,
129-133
|
| 30.
|
Zhang, O.,
Kay, L. E.,
Olivier, J. P.,
and Forman-Kay, J. D.
(1994)
J. Biomol. NMR
4,
845-858
|
| 31.
|
Edelmann, L.,
Hanson, P. I.,
Chapman, E. R.,
and Jahn, R.
(1995)
EMBO J.
14,
224-231
|
| 32.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685
|
| 33.
|
Poirier, M. A.,
Hao, J. C.,
Malkus, P. N.,
Chan, C.,
Moore, M. F.,
King, D. S.,
and Bennett, M. K.
(1998)
J. Biol. Chem.
273,
11370-11377
|
| 34.
|
Shao, X.,
Li, C.,
Fernandez, I.,
Zhang, X.,
Südhof, T. C.,
and Rizo, J.
(1997)
Neuron
18,
133-142
|
| 35.
|
Hazzard, J.,
Südhof, T. C.,
and Rizo, J.
(1999)
J. Biomol. NMR
14,
203-207
|
| 36.
|
Yang, B.,
Gonzalez, L., Jr.,
Prekeris, R.,
Steegmaier, M.,
Advani, R. J.,
and Scheller, R. H.
(1999)
J. Biol. Chem.
274,
5649-5653
|
| 37.
|
Morgans, C. W.,
Brandstatter, J. H.,
Kellerman, J.,
Betz, H.,
and Wassle, H.
(1996)
J. Neurosci.
16,
6713-6721
|
| 38.
|
Montecucco, C.,
Papini, E.,
and Schiavo, G.
(1996)
Experientia (Basel)
52,
1026-1032
|
| 39.
|
Hata, Y.,
Slaughter, C. A.,
and Südhof, T. C.
(1993)
Nature
366,
347-351
|
| 40.
|
Xu, T.,
Rammner, B.,
Margittai, M.,
Artalejo, A. R.,
Neher, E.,
and Jahn, R.
(1999)
Cell
99,
713-722
|
| 41.
|
Tokumaru, H.,
Ishizuka, T.,
Umayahara, K.,
Pelligrini, L. L.,
Betz, H.,
Augustine, G. J.,
and Abe, T.
(1999)
Abstr. Soc. Neurosci.
25,
1748
|
| 42.
|
Lacroix, E.,
Viguera, A. R.,
and Serrano, L.
(1998)
J. Mol. Biol.
284,
173-191
|
| 43.
|
Bruns, D.,
Engers, S.,
Yang, C.,
Ossig, R.,
Jeromin, A.,
and Jahn, R.
(1997)
J. Neurosci.
17,
1898-1910
|
Copyright © 2000 by The American Society for Bioch